158 related articles for article (PubMed ID: 37822513)
1. Efficacy and Safety of Low-dose Oral Prednisolone for Patients with Refractory Hunner-type Interstitial Cystitis.
Akiyama Y; Niimi A; Nomiya A; Taguchi S; Yamada Y; Sato Y; Yamada D; Maeda D; Ushiku T; Kume H; Homma Y
Eur Urol Open Sci; 2023 Oct; 56():1-8. PubMed ID: 37822513
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of intravesical dimethyl sulfoxide treatment for patients with refractory Hunner-type interstitial cystitis: Real-world data postofficial approval in Japan.
Akiyama Y; Niimi A; Nomiya A; Taguchi S; Yamada Y; Sato Y; Kawai T; Yamada D; Kume H; Homma Y
Int J Urol; 2024 Feb; 31(2):111-118. PubMed ID: 37817647
[TBL] [Abstract][Full Text] [Related]
3. The O'Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution.
Yoshimura N; Uno T; Sasaki M; Ohinata A; Nawata S; Ueda T
Int J Urol; 2022 Apr; 29(4):289-296. PubMed ID: 34929761
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
5. Cystectomy for patients with Hunner-type interstitial cystitis at a tertiary referral center in Japan.
Akiyama Y; Niimi A; Igawa Y; Nomiya A; Yamada Y; Sato Y; Kawai T; Yamada D; Kume H; Homma Y
Low Urin Tract Symptoms; 2022 Mar; 14(2):102-108. PubMed ID: 34704374
[TBL] [Abstract][Full Text] [Related]
6. [EARLY EXPERIENCE OF INTRAVESICAL INSTILLATION OF DIMETHYL SULFOXIDE 50% SOLUTION FOR HUNNER TYPE INTERSTITIAL CYSTITIS IN A CLINIC].
Nanri M; Matsuo M
Nihon Hinyokika Gakkai Zasshi; 2022; 113(4):122-127. PubMed ID: 37866931
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients: A Prospective Randomized Controlled Trial.
Ko KJ; Cho WJ; Lee YS; Choi J; Byun HJ; Lee KS
Eur Urol; 2020 May; 77(5):644-651. PubMed ID: 31959549
[TBL] [Abstract][Full Text] [Related]
8. Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.
Akiyama Y; Niimi A; Nomiya A; Yamada Y; Nakagawa T; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
Neurourol Urodyn; 2018 Apr; 37(4):1441-1447. PubMed ID: 29315774
[TBL] [Abstract][Full Text] [Related]
9. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.
Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y
Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.
Niimi A; Igawa Y; Aizawa N; Honma T; Nomiya A; Akiyama Y; Kamei J; Fujimura T; Fukuhara H; Homma Y
Neurourol Urodyn; 2018 Mar; 37(3):1113-1119. PubMed ID: 29048741
[TBL] [Abstract][Full Text] [Related]
11. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
[TBL] [Abstract][Full Text] [Related]
12. Reduction of Bladder Capacity Under Anesthesia Following Multiple Recurrences and Repeated Surgeries of Hunner Lesions in Patients With Interstitial Cystitis.
Furuta A; Suzuki Y; Igarashi T; Kimura T; Egawa S; Yoshimura N
Int Neurourol J; 2022 Mar; 26(1):45-51. PubMed ID: 35368185
[TBL] [Abstract][Full Text] [Related]
13. Daily low dose of tadalafil improves pain and frequency in bladder pain syndrome/interstitial cystitis patients.
Mendes PA; Dias N; Simaes J; Dinis P; Cruz F; Pinto R
Turk J Urol; 2022 Jan; 48(1):82-87. PubMed ID: 35118993
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study.
Yoshimura N; Homma Y; Tomoe H; Otsuka A; Kitta T; Masumori N; Akiyama Y; Niimi A; Mitsui T; Nanri M; Namima T; Takei M; Yamaguchi A; Sekiguchi Y; Kajiwara M; Kobayashi S; Ameda K; Ohashi Y; Sakamoto S; Muraki O; Shishido T; Kageyama S; Kokura K; Okazoe H; Yamanishi T; Watanabe T; Uno T; Ohinata A; Ueda T
Int J Urol; 2021 May; 28(5):545-553. PubMed ID: 33580603
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion.
Kim HJ; Lee JS; Cho WJ; Lee HS; Lee HN; You HW; Jung W; Lee KS
Int J Urol; 2014 Apr; 21 Suppl 1():69-73. PubMed ID: 24807503
[TBL] [Abstract][Full Text] [Related]
16. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
17. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
[TBL] [Abstract][Full Text] [Related]
18. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion.
Choi D; Han JY; Shin JH; Ryu CM; Yu HY; Kim A; Lee S; Lim J; Shin DM; Choo MS
Sci Rep; 2018 Jun; 8(1):9782. PubMed ID: 29955137
[TBL] [Abstract][Full Text] [Related]
20. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
